Back to Search
ANDREW LICHTMAN, M.D.
M.D.
Anatomic Pathology Physician
NPI: 1538288782Individual
Specialties, Licenses & Credentials
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
53976(MA)
Research & Publications (20)
Food for thought: endocannabinoid modulation of lipogenesis.
PMID 15864340·J Clin Invest·2005
7-preclinical
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.
PMID 15229230·J Pharmacol Exp Ther·2004
7-preclinical
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
PMID 15157693·Pain·2004
4-observational
Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
PMID 12065702·J Pharmacol Exp Ther·2002
7-preclinical
Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
PMID 11504797·J Pharmacol Exp Ther·2001
7-preclinical
The pharmacological activity of inhalation exposure to marijuana smoke in mice.
PMID 11376914·Drug Alcohol Depend·2001
7-preclinical
Pharmacological evaluation of aerosolized cannabinoids in mice.
PMID 10884513·Eur J Pharmacol·2000
7-preclinical
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats.
PMID 10980277·Eur J Pharmacol·2000
7-preclinical
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
PMID 19502530·J Pharmacol Exp Ther·2009
7-preclinical
Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task.
PMID 19524055·Neurobiol Learn Mem·2009
4-observational
Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
PMID 19430909·AAPS J·2009
7-preclinical
Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
PMID 19118134·J Pharmacol Exp Ther·2009
7-preclinical
Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
PMID 19168707·J Pharmacol Exp Ther·2009
7-preclinical
Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
PMID 19184452·AAPS J·2009
6-review
The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1.
PMID 19226258·Br J Pharmacol·2009
6-review
Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
PMID 19322169·Neuropsychopharmacology·2009
7-preclinical
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
PMID 19679411·Drug Alcohol Depend·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- BRIGHAM & WOMEN'S HOSPITAL, 75 FRANCIS STREET
BOSTON, MA 02115 - Phone
- (617) 525-4335
Quick Facts
- NPI
- 1538288782
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile